Trial Profile
Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Diabetic angiopathies
- Focus Pharmacodynamics
- 18 May 2007 New trial record.